Our previous research demonstrated that Morgana is expressed at very low levels in the BM cells of patients affected by MDS/MPN with neutrophilia and is robustly downregulated in 30% of Ph + CML patients in chronic phase11. The gene discussed is CHORDC1; the disease is myeloproliferative neoplasm.